Natural, edible treatment offers promise for diabetics

June 28, 2013

A potentially revolutionary treatment for diabetics mimics the benefits of major surgery, but achieves the same results without it.

The American Heart Association's Science & Technology Accelerator investment catalyst division is investing in an oral treatment that delivers natural substances, dramatically improving blood sugar levels in diabetics. This collaborative investment, with Broadview Ventures and North Carolina Biotechnology Center, holds the promise of replacing synthetic drugs for thousands of Type 2 diabetics.

"The use of natural, nontoxic dietary compounds—delivered in a new way to achieve the same amazing improvements in blood sugar observed in diabetics who have undergone intestinal surgery—could be a game-changer, helping dramatically start decreasing the incidence of heart attack and stroke within the next five years," said Joseph A. Hill, M.D., Ph.D., chief of cardiology at UT Southwestern Medical Center.

Here's how the benefits could translate from the operating room to a simple oral treatment. Morbidly obese diabetics often undergo intestinal bypass surgery to lose weight. The surgery shortens the small intestine so that just a fraction of calories ingested have time to be absorbed in the small intestine before reaching the colon, where waste is handled. These diabetics appear virtually "cured" of their diabetes before they leave the operating room.

The likely reason is that two nutrients in everyone's diet, Sodium Butyrate and L-Glutamine, are normally absorbed shortly after they leave the stomach, but they reach the colon after such gut-shortening surgery. The colon has receptors that bind with them, causing a massive increase in insulin secretion and a decrease in insulin resistance.

Non-obese diabetics are not candidates for intestinal bypass surgery, but the innovators have found a way to create an "artificial short gut" with a capsule that delivers these nutrients from mouth to colon, lowering blood glucose to normal.

"This has the potential to save thousands of lives each year and save an already overburdened healthcare system billions of dollars," said Russell Vester, M.D., a cardiovascular surgeon and current member of the Science & Technology Accelerator's investment committee.

"The patients' blood glucose is normalized before they've lost an ounce. It appears, in many of them, as if they never had in the first place," said Ross Tonkens, M.D., a cardiologist and head of the American Heart Association's Science & Technology Accelerator Fund.

"Many diabetics could be moved from prosthetic drugs (which the FDA is scrutinizing for toxicities including increasing incidence of pancreatic cancer) to natural substances with no toxicities," Tonkens said. "The implications are huge."

Explore further: Obesity surgery-diabetes study shows pros and cons

Related Stories

Obesity surgery-diabetes study shows pros and cons

June 4, 2013

Obesity surgery worked much better at reducing and even reversing diabetes than medication and lifestyle changes in one of the most rigorous studies of its kind. But the researchers and others warn that possible serious complications ...

Insulin resistance linked to weaker bones

June 17, 2013

Reduced effectiveness of the hormone insulin, or insulin resistance, is associated with weakened bones, a clinical study shows. The results were presented Sunday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Recommended for you

How does friendly fire happen in the pancreas?

October 21, 2016

In type 1 diabetes, the body attacks its own insulin-producing cells. Scientists at Helmholtz Zentrum München, partner in the German Center for Diabetes Research, and their colleagues at Technical University of Munich have ...

Diabetes opens floodgates to fructose

October 11, 2016

Fructose, once seen as diabetics' alternative to glucose, is fast-tracked to the liver in diabetic mice and contributes to metabolic diseases, according to new research from Harvard University.

Type 2 diabetes and obesity—what do we really know?

October 6, 2016

Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world. In a review in Science, Mark McCarthy, professor at the University of Oxford, UK, and Paul Franks, professor at Lund ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.